Koers Nexeon MedSystems Inc. Other OTC
Aandelen
NXNN
US65342G2030
Geavanceerde medische apparatuur & technologie
Omzet 2016 | - | Omzet 2017 | 3,3 3,04 | Marktkapitalisatie | 49,02 mln. 45,1 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | -1 mln. -920K | Nettowinst (verlies) 2017 | -2 mln. -1,84 mln. | EV/omzet 2016 * | - |
Nettoliquiditeiten 2016 | 2,01 mln. 1,85 mln. | Nettoschuld 2017 | 3,33 mln. 3,07 mln. | EV/omzet 2017 | 15.849.303 x |
K/w-verhouding 2016 * |
-
| K/w-verhouding 2017 |
-20,5
x | Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 |
-
| Vrij verhandelbaar | 49,16% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Director of Finance/CFO | 55 | 01-12-15 | |
Daniel P. Powell
SAM | Sales & Marketing | 48 | 26-06-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Neitzel
BRD | Director/Board Member | 44 | 01-01-17 |
Kent J. George
BRD | Director/Board Member | 63 | 01-01-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,15% | 227 mld. | |
+14,90% | 197 mld. | |
+18,22% | 141 mld. | |
+29,15% | 110 mld. | |
+0,53% | 64,15 mld. | |
+16,92% | 53,72 mld. | |
+6,33% | 51,75 mld. | |
+10,93% | 45,2 mld. | |
+5,87% | 37,37 mld. |